Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease
Summary
Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease; Provides an appropriation for the Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease. APPROPRIATION: $50,000
Bill status
vetoed
2 of 3 stages cleared
Introduction
Mar 2021
Committee Review
Feb 2021
Vetoed
Jun 2021
Introduced Mar 2, 2021
Vetoed Jun 2, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
7
Key actions
1
Committee
3
Jun 2, 2021
Vetoed
Vetoed by Governor; See SB 2500 (line item 468)
legislature
Feb 14, 2021
Lower · Passed
Now in Health Care Appropriations Subcommittee
lower
Feb 14, 2021
Committee
Referred to Appropriations Committee
lower
Feb 14, 2021
Committee
Referred to Health Care Appropriations Subcommittee
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Emily Slosberg-King
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 3551
Scope: FL
Hi! I can help you understand HB 3551. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline